Takeda Pharmaceutical: Neurocrine Biosciences and Takeda amend strategic collaboration to develop and commercialize osavampator
Neurocrine Biosciences, Inc., is a leading neuroscience─focused, biopharmaceutical company, announced it has amended its agreement with Takeda to develop and commercialize osavampator
Read full article »
Takeda is a Japan-based pharmaceutical firm that develops and markets medicinal drugs and vaccines for the treatment of diseases in areas such as neuroscience and oncology.
Read more